RSS - Posts
A new company developing diagnostics for neurological and other disorders based on environmental exposures is raising $16 million in venture funds. . . . → Read More: Environmental Biomarker Start-Up Gains $16M in Early Funds
|
|||||
      |
 One comment - (Comments are closed)  Finance, New products  biomedical, biotechnology, chemistry, entrepreneurs, equity, FDA, investment, licensing, life sciences, mathematics, medical device, physical sciences, physics, robotics, university, venture capital 
An international health organization is evaluating a new type of vaccine made with biodegradable RNA nanoparticles to help head off future viral pandemics. . . . → Read More: CEPI Assessing Advanced RNA Nanoparticle Vaccine One comment - (Comments are closed) Finance, Joint ventures/collaborations biomedical, biotechnology, chemistry, Covid-19, entrepreneurs, Europe, genomics, grant, life sciences, nanotechnology, pharmaceuticals, physical sciences, university 
A bioengineering team devised techniques for feasibly adding cancer-killing enzymes to engineered immune cells that in lab mice kill solid-tumor and blood cancer cells. . . . → Read More: Nanotech Enzyme Process Boosts T-Cell Cancer Therapies Comments are closed New products biomedical, biotechnology, cancer, chemistry, engineering, life sciences, manufacturing, materials science, nanotechnology, pharmaceuticals, physical sciences, preclinical, university 
Some 20,000 dogs and cats are expected to have their genomes sequenced in the next 10 years for a publicly available database to enable precision medicine for pets. . . . → Read More: Project to Sequence 20K Dog and Cat Genomes Comments are closed Joint ventures/collaborations biomedical, genomics, health care, life sciences, mathematics, medical device, NIH, physical sciences, U.K., university 
An enterprise discovering new drugs with optical light-based protein chemistry is emerging from stealth, including work with biopharmaceutical company Genentech. . . . → Read More: Protein Chemistry Biotech Gains Collaboration, Venture Funds 2 comments - (Comments are closed) Finance, Joint ventures/collaborations, New products biomedical, biotechnology, cancer, chemistry, entrepreneurs, equity, investment, life sciences, mathematics, pharmaceuticals, physical sciences, preclinical, university 
Engineers and neuroscientists developed a circuit that in lab mice connects implanted lab-grown brain tissue to the brain’s cognitive center and responds to visual stimuli. . . . → Read More: Implanted Organoid Connects to Brain, Reacts to Visual Cues Comments are closed New products biomedical, computer science, engineering, life sciences, materials science, medical device, physical sciences, preclinical, semiconductors, stem cells, university 
A discoverer of therapeutic peptides signed licensing deals in the past few days with two drug makers that could bring the company as much as $3.3 billion. . . . → Read More: Peptide Discovery Company to Gain $3.3B in Licensing Deals One comment - (Comments are closed) Intellectual property, Joint ventures/collaborations, New products Asia, biomedical, biotechnology, cancer, chemistry, Japan, licensing, life sciences, pharmaceuticals, physical sciences, university 
A new company creating protein ingredients for food products from carbon dioxide converted by engineered bacteria is raising €4 million more in seed funds. . . . → Read More: Food Protein Biotech Adds €4M in Seed Funds Comments are closed Finance, New products agriculture, biotechnology, chemistry, energy, entrepreneurs, equity, Europe, investment, life sciences, physical sciences, university, venture capital 
A new company developing 3-D cell and tissue models of lymph nodes for discovery of immunotherapies is raising $4.3 million in seed funds. . . . → Read More: Immune Organoid Company Raises $4.3M in Seed Funds Comments are closed Finance, New products biomedical, biotechnology, engineering, entrepreneurs, equity, investment, life sciences, mathematics, pharmaceuticals, physical sciences, university, venture capital 
Results of a clinical trial indicate a gel applied to lesions caused by basal cell carcinoma is safe for patients and clears the cancerous skin tumors. . . . → Read More: Trial Shows Gel Clears Common Skin Cancer Wounds Comments are closed New products biomedical, biotechnology, cancer, chemistry, clinical trials, Israel, life sciences, pharmaceuticals, physical sciences, university |
||||
|
Copyright © 2023 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||